CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Carbylan Therapeutics, Inc.  (CBYL)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Carbylan Therapeutics's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

CBYL Gross Margin (Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
(Sep 30 2015)
III. Quarter
Y / Y Revenue Change 0 % 0 % 0 % - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 57 # 80 # 63 # 667 # 50
Seq. Revenue Change 0 % 0 % -12.5 % 14.29 % 0 %
Seq. Gross Profit Change - - - - -


Commenting Third Quarter 2016 Gross Margin
Carbylan Therapeutics, Inc. experienced contraction in Gross Profit by 0 % to $0 millions and Revenue by 0 %, while Gross Margin fell to 100 % a new company low.

Observing third quarter 2016 results within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Gross Margin. While Gross Margin total ranking has impoved so far to 57, from total ranking in previous quarter at 80.
Learn about Gross Margin
CBYL's Gross Margin third quarter 2016 Company Ranking
Within: No.
Industry # 5
Sector # 10
S&P 500 # 57

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Sep 30 2016)  

You need to upgrade your Flash Player


Financial Statements
Carbylan Therapeutics's (Sep 30 2016) Gross Profit $ 0 CBYL's Income Statement
Carbylan Therapeutics's (Sep 30 2015) Gross Profit $ 0 Quarterly CBYL's Growth
CBYL's Profits by Division See CBYL's Profits by Segment

Other Gross Margin Profitability Ratios
CBYL's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
CBYL's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for CBYL's Competitors
Gross Margin Profit Margin for Carbylan Therapeutics's Suppliers
Gross Margin Profit Margin for CBYL's Customers

You may also want to know
CBYL's Annual Growth Rates CBYL's Profitability Ratios CBYL's Asset Turnover Ratio CBYL's Dividend Growth
CBYL's Roe CBYL's Valuation Ratios CBYL's Financial Strength Ratios CBYL's Gross Profit Growth
CBYL's Roa CBYL's Inventory Turnover Ratio CBYL's Growth Rates CBYL's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Sep 30 2016, within Major Pharmaceutical Preparations Industry Gross MarginSep 30 2016 MRQ Gross ProfitSep 30 2016 MRQ Revenue
Jazz Pharmaceuticals Plc  100.00 %$ 374.181 $ 374.181 
Karyopharm Therapeutics Inc.  100.00 %$ 0.048 $ 0.048 
Abeona Therapeutics Inc.  100.00 %$ 0.184 $ 0.184 
Ionis Pharmaceuticals Inc  100.00 %$ 110.927 $ 110.927 
Ironwood Pharmaceuticals Inc  100.00 %$ 66.106 $ 66.106 
Lexicon Pharmaceuticals, Inc.  100.00 %$ 27.717 $ 27.717 
Seres Therapeutics, Inc.  100.00 %$ 13.015 $ 13.015 
Northwest Biotherapeutics Inc  100.00 %$ 0.159 $ 0.159 
Ocera Therapeutics, Inc.  100.00 %$ 0.038 $ 0.038 
Newlink Genetics Corp  100.00 %$ 15.345 $ 15.345 
Mast Therapeutics, Inc.  100.00 %$ 0.045 $ 0.045 
Macrogenics Inc  100.00 %$ 3.255 $ 3.255 
Intercept Pharmaceuticals Inc  100.00 %$ 5.177 $ 5.177 
Ibio, Inc.  100.00 %$ 0.135 $ 0.135 
Enanta Pharmaceuticals Inc  100.00 %$ 12.841 $ 12.841 
Epizyme, Inc.  100.00 %$ 6.584 $ 6.584 
Endocyte Inc  100.00 %$ 0.033 $ 0.033 
Eleven Biotherapeutics, Inc.  100.00 %$ 28.650 $ 28.650 
Dicerna Pharmaceuticals Inc  100.00 %$ 0.162 $ 0.162 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.274 $ 0.274 
Fibrogen Inc  100.00 %$ 30.102 $ 30.102 
Heat Biologics, Inc.  100.00 %$ 0.220 $ 0.220 
Genvec Inc  100.00 %$ 0.173 $ 0.173 
Glycomimetics Inc  100.00 %$ 0.019 $ 0.019 
Geron Corp  100.00 %$ 5.108 $ 5.108 
Oncomed Pharmaceuticals Inc  100.00 %$ 5.919 $ 5.919 
Onconova Therapeutics, Inc.  100.00 %$ 1.651 $ 1.651 
Stemline Therapeutics Inc  100.00 %$ 0.299 $ 0.299 
Innoviva, Inc.  100.00 %$ 33.309 $ 33.309 
Steadymed Ltd.  100.00 %$ 0.276 $ 0.276 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
CHRE's Profile
Stock Price
CHRE's Financials
CHRE's Expectations
Business Description
Fundamentals
Charts & Quotes
CHRE's News
Suppliers
CHRE's Competitors
Customers & Markets
Economic Indicators
CHRE's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com